Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Seminars in Hematology|March 22, 2006
Purine analogue combinations for indolent lymphomasNicholas Di Bella, Farhad RavandiCancer|January 27, 2005
An open-label pilot study of pentostatin, mitoxantrone, and rituximab in patients with previously untreated, Stage III or IV, low-grade non-Hodgkin lymphomaNicholas Di Bella, Craig Reynolds, David Faragher, et al.Clinical Lymphoma|September 30, 2004
Results of a phase II multicenter trial of single-agent gemcitabine in patients with relapsed or chemotherapy-refractory Hodgkin's lymphomaHemachandra Venkatesh, Nicholas Di Bella, Thomas P Flynn, et al.Investigational New Drugs|September 17, 2011
A Phase III trial of fludarabine, cyclophosphamide, and rituximab vs. pentostatin, cyclophosphamide, and rituximab in B-cell chronic lymphocytic leukemiaCraig Reynolds, Nicholas Di Bella, Roger M Lyons, et al.Blood|December 8, 2009
Results of a phase 2 study of bortezomib in patients with relapsed or refractory indolent lymphomaNicholas Di Bella, Raymond Taetle, Kathryn Kolibaba, et al.Pageof 1